NM_001220500.2:c.892G>A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001220500.2(FCER2):c.892G>A(p.Glu298Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,613,872 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001220500.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCER2 | NM_001220500.2 | c.892G>A | p.Glu298Lys | missense_variant | Exon 11 of 11 | ENST00000597921.6 | NP_001207429.1 | |
FCER2 | NM_002002.5 | c.892G>A | p.Glu298Lys | missense_variant | Exon 11 of 11 | NP_001993.2 | ||
FCER2 | NM_001207019.3 | c.889G>A | p.Glu297Lys | missense_variant | Exon 10 of 10 | NP_001193948.2 | ||
FCER2 | XM_005272462.5 | c.892G>A | p.Glu298Lys | missense_variant | Exon 11 of 11 | XP_005272519.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000683 AC: 104AN: 152182Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000173 AC: 43AN: 248188 AF XY: 0.000112 show subpopulations
GnomAD4 exome AF: 0.0000609 AC: 89AN: 1461572Hom.: 1 Cov.: 31 AF XY: 0.0000619 AC XY: 45AN XY: 727068 show subpopulations
GnomAD4 genome AF: 0.000683 AC: 104AN: 152300Hom.: 1 Cov.: 32 AF XY: 0.000725 AC XY: 54AN XY: 74464 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.892G>A (p.E298K) alteration is located in exon 11 (coding exon 10) of the FCER2 gene. This alteration results from a G to A substitution at nucleotide position 892, causing the glutamic acid (E) at amino acid position 298 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at